120 related articles for article (PubMed ID: 17420603)
1. Prevention of pathogenic Escherichia coli infection in mice and stimulation of macrophage activation in rats by an oral administration of probiotic Lactobacillus casei I-5.
Ishida-Fujii K; Sato R; Goto S; Yang XP; Kuboki H; Hirano S; Sato M
Biosci Biotechnol Biochem; 2007 Apr; 71(4):866-73. PubMed ID: 17420603
[TBL] [Abstract][Full Text] [Related]
2. Oral administration of Lactobacillus gasseri TMC0356 stimulates peritoneal macrophages and attenuates general symptoms caused by enteropathogenic Escherichia coli infection.
Yoda K; He F; Kawase M; Miyazawa K; Hiramatsu M
J Microbiol Immunol Infect; 2014 Apr; 47(2):81-6. PubMed ID: 23079484
[TBL] [Abstract][Full Text] [Related]
3. Immunization with recombinant Lactobacillus casei strains producing K99, K88 fimbrial protein protects mice against enterotoxigenic Escherichia coli.
Wen LJ; Hou XL; Wang GH; Yu LY; Wei XM; Liu JK; Liu Q; Wei CH
Vaccine; 2012 May; 30(22):3339-49. PubMed ID: 21856357
[TBL] [Abstract][Full Text] [Related]
4. Effect of fermented milk containing probiotic bacteria in the prevention of an enteroinvasive Escherichia coli infection in mice.
Medici M; Vinderola CG; Weill R; Perdigón G
J Dairy Res; 2005 May; 72(2):243-9. PubMed ID: 15909691
[TBL] [Abstract][Full Text] [Related]
5. Selective effects of Lactobacillus casei Shirota on T cell activation, natural killer cell activity and cytokine production.
Dong H; Rowland I; Tuohy KM; Thomas LV; Yaqoob P
Clin Exp Immunol; 2010 Aug; 161(2):378-88. PubMed ID: 20456417
[TBL] [Abstract][Full Text] [Related]
6. Lysate of probiotic Lactobacillus casei DN-114 001 ameliorates colitis by strengthening the gut barrier function and changing the gut microenvironment.
Zakostelska Z; Kverka M; Klimesova K; Rossmann P; Mrazek J; Kopecny J; Hornova M; Srutkova D; Hudcovic T; Ridl J; Tlaskalova-Hogenova H
PLoS One; 2011; 6(11):e27961. PubMed ID: 22132181
[TBL] [Abstract][Full Text] [Related]
7. Stimulation of innate immunity by oral administration of dahi containing probiotic Lactobacillus casei in mice.
Jain S; Yadav H; Sinha PR
J Med Food; 2008 Dec; 11(4):652-6. PubMed ID: 19053856
[TBL] [Abstract][Full Text] [Related]
8. Lactobacillus casei HY7213 ameliorates cyclophosphamide-induced immunosuppression in mice by activating NK, cytotoxic T cells and macrophages.
Jang SE; Joh EH; Ahn YT; Huh CS; Han MJ; Kim DH
Immunopharmacol Immunotoxicol; 2013 Jun; 35(3):396-402. PubMed ID: 23672525
[TBL] [Abstract][Full Text] [Related]
9. Probiotic
Rocha-Ramírez LM; Pérez-Solano RA; Castañón-Alonso SL; Moreno Guerrero SS; Ramírez Pacheco A; García Garibay M; Eslava C
J Immunol Res; 2017; 2017():4607491. PubMed ID: 28758133
[No Abstract] [Full Text] [Related]
10. Oral immunization of mice with a probiotic Lactobacillus casei constitutively expressing the α-toxoid induces protective immunity against Clostridium perfringens α-toxin.
Gao X; Ma Y; Wang Z; Bai J; Jia S; Feng B; Jiang Y; Cui W; Tang L; Li Y; Wang L; Xu Y
Virulence; 2019 Dec; 10(1):166-179. PubMed ID: 30806148
[TBL] [Abstract][Full Text] [Related]
11. Lactobacillus casei CRL 431 administration decreases inflammatory cytokines in a diet-induced obese mouse model.
Novotny Núñez I; Maldonado Galdeano C; de Moreno de LeBlanc A; Perdigón G
Nutrition; 2015; 31(7-8):1000-7. PubMed ID: 26059375
[TBL] [Abstract][Full Text] [Related]
12.
Wang Y; Yan X; Zhang W; Liu Y; Han D; Teng K; Ma Y
J Microbiol Biotechnol; 2019 Jun; 29(6):863-876. PubMed ID: 31091863
[TBL] [Abstract][Full Text] [Related]
13. Lactobacillus brevis G-101 ameliorates colitis in mice by inhibiting NF-κB, MAPK and AKT pathways and by polarizing M1 macrophages to M2-like macrophages.
Jang SE; Hyam SR; Han MJ; Kim SY; Lee BG; Kim DH
J Appl Microbiol; 2013 Sep; 115(3):888-96. PubMed ID: 23742179
[TBL] [Abstract][Full Text] [Related]
14. Stimulation of macrophages by immunobiotic Lactobacillus strains: influence beyond the intestinal tract.
Marranzino G; Villena J; Salva S; Alvarez S
Microbiol Immunol; 2012 Nov; 56(11):771-81. PubMed ID: 22846065
[TBL] [Abstract][Full Text] [Related]
15. Comparative study of the protective capacity against Salmonella infection between probiotic and nonprobiotic Lactobacilli.
Castillo NA; de Moreno de LeBlanc A; M Galdeano C; Perdigón G
J Appl Microbiol; 2013 Mar; 114(3):861-76. PubMed ID: 23163296
[TBL] [Abstract][Full Text] [Related]
16. Lactobacillus plantarum CLP-0611 ameliorates colitis in mice by polarizing M1 to M2-like macrophages.
Jang SE; Han MJ; Kim SY; Kim DH
Int Immunopharmacol; 2014 Jul; 21(1):186-92. PubMed ID: 24815859
[TBL] [Abstract][Full Text] [Related]
17. Probiotic Lactobacillus casei expressing human lactoferrin elevates antibacterial activity in the gastrointestinal tract.
Chen HL; Lai YW; Chen CS; Chu TW; Lin W; Yen CC; Lin MF; Tu MY; Chen CM
Biometals; 2010 Jun; 23(3):543-54. PubMed ID: 20148305
[TBL] [Abstract][Full Text] [Related]
18. Suppressive effect on activation of macrophages by Lactobacillus casei strain Shirota genes determining the synthesis of cell wall-associated polysaccharides.
Yasuda E; Serata M; Sako T
Appl Environ Microbiol; 2008 Aug; 74(15):4746-55. PubMed ID: 18552190
[TBL] [Abstract][Full Text] [Related]
19. Probiotic Lactobacillus casei strain Shirota prevents indomethacin-induced small intestinal injury: involvement of lactic acid.
Watanabe T; Nishio H; Tanigawa T; Yamagami H; Okazaki H; Watanabe K; Tominaga K; Fujiwara Y; Oshitani N; Asahara T; Nomoto K; Higuchi K; Takeuchi K; Arakawa T
Am J Physiol Gastrointest Liver Physiol; 2009 Sep; 297(3):G506-13. PubMed ID: 19589943
[TBL] [Abstract][Full Text] [Related]
20. Effect of probiotic strains of lacto- and bifidobacteria on the activity of macrophages and other parameters of immunity in cases of staphylococcosis.
Mokrozub VV; Lazarenko LM; Babenko LP; Shynkarenko-Sichel LM; Olevinska ZM; Timoshok NO; Pidgorskyi VS; Spivak MY
Mikrobiol Z; 2012; 74(6):90-8. PubMed ID: 23293832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
